Kolexia
Herbrecht Raoul
Oncologie médicale
Gcs Icans - Et Expl.
Strasbourg, France
236 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mycoses Aspergillose Infections fongiques invasives Mucormycose Tumeurs hématologiques Candidose Lymphomes Leucémies Neutropénie

Industries

Pfizer
6 collaboration(s)
Dernière en 2020
Gilead
5 collaboration(s)
Dernière en 2022
MundiPharma
2 collaboration(s)
Dernière en 2022
PASCALEO
2 collaboration(s)
Dernière en 2020

Dernières activités

FungiScope - A Global Emerging Fungal Infection Registry
Essai Clinique (Cidara Therapeutics Inc.)   04 décembre 2023
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
American journal of hematology   19 octobre 2023
Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.
Chest   05 juillet 2023
OASIS: Phase III, Adjudicator-blinded, Randomised Study to Evaluate Efficacy and Safety of Treatment With Olorofim Versus Treatment With AmBisome® Followed by Standard of Care in Patients With Invasive Fungal Disease Caused by Aspergillus Species
Essai Clinique (F2G Biotech GmbH)   31 mai 2023
Invasive Pulmonary Aspergillosis.
Journal of fungi (Basel, Switzerland)   17 janvier 2023
FORMULA-OLS: Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Essai Clinique (F2G Biotech GmbH)   30 novembre 2022
Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   19 septembre 2022
Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
Leukemia   06 mai 2022
Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study.
BMC infectious diseases   09 avril 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
Leukemia   02 avril 2022